<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Tue, 15 Aug 2023 04:09:23 +0000</lastbuilddate>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Late breaking trials in heart failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579050/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 14;44(31):2877-2882. doi: 10.1093/eurheartj/ehad516.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579050/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579050</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad516>10.1093/eurheartj/ehad516</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579050</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Late breaking trials in heart failure</dc:title>
<dc:identifier>pmid:37579050</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad516</dc:identifier>
</item>
<item>
<title>Correction to: Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579015/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):e7. doi: 10.1161/CIR.0000000000001176. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579015/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579015</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001176>10.1161/CIR.0000000000001176</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579015</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?</dc:title>
<dc:identifier>pmid:37579015</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001176</dc:identifier>
</item>
<item>
<title>BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579014/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):607-609. doi: 10.1161/CIRCULATIONAHA.123.065946. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579014/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579014</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065946>10.1161/CIRCULATIONAHA.123.065946</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579014</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Hisashi Sawada</dc:creator>
<dc:creator>Alan Daugherty</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies</dc:title>
<dc:identifier>pmid:37579014</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065946</dc:identifier>
</item>
<item>
<title>Correction to: Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579013/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):e6. doi: 10.1161/CIR.0000000000001175. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579013/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579013</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001175>10.1161/CIR.0000000000001175</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579013</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37579013</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001175</dc:identifier>
</item>
<item>
<title>Correction to: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579012/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):e5. doi: 10.1161/CIR.0000000000001172. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579012/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579012</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001172>10.1161/CIR.0000000000001172</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579012</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:37579012</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001172</dc:identifier>
</item>
<item>
<title>Response by Sarma and Levine to Letters Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579011/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):620-621. doi: 10.1161/CIRCULATIONAHA.123.065133. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579011/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579011</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065133>10.1161/CIRCULATIONAHA.123.065133</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579011</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Satyam Sarma</dc:creator>
<dc:creator>Benjamin D Levine</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Sarma and Levine to Letters Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?"</dc:title>
<dc:identifier>pmid:37579011</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065133</dc:identifier>
</item>
<item>
<title>A Curious Presentation of Chronic Chest Pain</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579010/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):610-612. doi: 10.1161/CIRCULATIONAHA.123.065372. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579010/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579010</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065372>10.1161/CIRCULATIONAHA.123.065372</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579010</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Elmira Javanmardi</dc:creator>
<dc:creator>Frederick Ehlert</dc:creator>
<dc:creator>Hirad Yarmohammadi</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>A Curious Presentation of Chronic Chest Pain</dc:title>
<dc:identifier>pmid:37579010</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065372</dc:identifier>
</item>
<item>
<title>Letter by Wussler et al Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579009/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):619. doi: 10.1161/CIRCULATIONAHA.123.064413. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579009/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579009</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064413>10.1161/CIRCULATIONAHA.123.064413</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579009</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Desiree Wussler</dc:creator>
<dc:creator>Maria Belkin</dc:creator>
<dc:creator>Christian Mueller</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Wussler et al Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?"</dc:title>
<dc:identifier>pmid:37579009</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064413</dc:identifier>
</item>
<item>
<title>SERCA2a Protein Levels Are Unaltered in Human Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579008/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):613-616. doi: 10.1161/CIRCULATIONAHA.123.064513. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579008/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579008</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064513>10.1161/CIRCULATIONAHA.123.064513</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579008</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Isabella Ragone</dc:creator>
<dc:creator>Javier Barallobre-Barreiro</dc:creator>
<dc:creator>Kaloyan Takov</dc:creator>
<dc:creator>Konstantinos Theofilatos</dc:creator>
<dc:creator>Xiaoke Yin</dc:creator>
<dc:creator>Lukas Emanuel Schmidt</dc:creator>
<dc:creator>Nieves Domenech</dc:creator>
<dc:creator>Maria Generosa Crespo-Leiro</dc:creator>
<dc:creator>Stephanie M van der Voorn</dc:creator>
<dc:creator>Aryan Vink</dc:creator>
<dc:creator>Toon A B van Veen</dc:creator>
<dc:creator>Csaba Bödör</dc:creator>
<dc:creator>Béla Merkely</dc:creator>
<dc:creator>Tamás Radovits</dc:creator>
<dc:creator>Manuel Mayr</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>SERCA2a Protein Levels Are Unaltered in Human Heart Failure</dc:title>
<dc:identifier>pmid:37579008</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064513</dc:identifier>
</item>
<item>
<title>Letter by Dimopoulos and Nanas Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37579007/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 15;148(7):617-618. doi: 10.1161/CIRCULATIONAHA.123.063855. Epub 2023 Aug 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37579007/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37579007</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063855>10.1161/CIRCULATIONAHA.123.063855</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37579007</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Stavros Dimopoulos</dc:creator>
<dc:creator>Serafim Nanas</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Dimopoulos and Nanas Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?"</dc:title>
<dc:identifier>pmid:37579007</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.063855</dc:identifier>
</item>
<item>
<title>Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37577791/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>Shared decision-making is increasingly embraced in health care and recommended in cardiovascular guidelines. Patient involvement in health care decisions, patient-clinician communication, and models of patient-centered care are critical to improve health outcomes and to promote equity, but formal models and evaluation in cardiovascular care are nascent. Shared decision-making promotes equity by involving clinicians and patients, sharing the best available evidence, and recognizing the needs,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 14. doi: 10.1161/CIR.0000000000001162. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Shared decision-making is increasingly embraced in health care and recommended in cardiovascular guidelines. Patient involvement in health care decisions, patient-clinician communication, and models of patient-centered care are critical to improve health outcomes and to promote equity, but formal models and evaluation in cardiovascular care are nascent. Shared decision-making promotes equity by involving clinicians and patients, sharing the best available evidence, and recognizing the needs, values, and experiences of individuals and their families when faced with the task of making decisions. Broad endorsement of shared decision-making as a critical component of high-quality, value-based care has raised our awareness, although uptake in clinical practice remains suboptimal for a range of patient, clinician, and system issues. Strategies effective in promoting shared decision-making include educating clinicians on communication techniques, engaging multidisciplinary medical teams, incorporating trained decision coaches, and using tools (ie, patient decision aids) at appropriate literacy and numeracy levels to support patients in their cardiovascular decisions. This scientific statement shines a light on the limited but growing body of evidence of the impact of shared decision-making on cardiovascular outcomes and the potential of shared decision-making as a driver of health equity so that everyone has just opportunities. Multilevel solutions must align to address challenges in policies and reimbursement, system-level leadership and infrastructure, clinician training, access to decision aids, and patient engagement to fully support patients and clinicians to engage in the shared decision-making process and to drive equity and improvement in cardiovascular outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37577791/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37577791</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001162>10.1161/CIR.0000000000001162</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37577791</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Cheryl R Dennison Himmelfarb</dc:creator>
<dc:creator>Theresa M Beckie</dc:creator>
<dc:creator>Larry A Allen</dc:creator>
<dc:creator>Yvonne Commodore-Mensah</dc:creator>
<dc:creator>Patricia M Davidson</dc:creator>
<dc:creator>Grace Lin</dc:creator>
<dc:creator>Barbara Lutz</dc:creator>
<dc:creator>Erica S Spatz</dc:creator>
<dc:creator>American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Quality of Care and Outcomes Research; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; Council on Epidemiology and Prevention; and Stroke Council</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37577791</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001162</dc:identifier>
</item>
<item>
<title>From plasma triglycerides to triglyceride metabolism: effects on mortality in the Copenhagen General Population Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37575001/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSION: This study observed an increased risk of all-cause, cardiovascular, cancer, and other mortality with higher triglyceride metabolism. This was not explained by higher plasma triglycerides and body mass index. The hypothesis studied in the present paper should be further validated by isotope flux studies.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 14:ehad330. doi: 10.1093/eurheartj/ehad330. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: It is unclear whether higher triglyceride metabolism per se contributes to mortality separate from elevated triglyceride-rich lipoproteins and body mass index. This study tested the hypotheses that higher triglyceride metabolism, measured as higher plasma glycerol and β-hydroxybutyrate, is associated with increased all-cause, cardiovascular, cancer, and other mortality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: This study included 30 000 individuals nested within 109 751 individuals from the Copenhagen General Population Study. During a median follow-up of 10.7 years, 9897 individuals died (2204 from cardiovascular, 3366 from cancer, and 2745 from other causes), while none were lost to follow-up. In individuals with glycerol >;80 µmol/L (highest fourth) vs. individuals with glycerol &lt;52 µmol/L (lowest fourth), the multivariable adjusted hazard ratio for all-cause mortality was 1.31 (95% confidence interval 1.22-1.40). In individuals with β-hydroxybutyrate >;154 µmol/L (highest fourth) vs. individuals with β-hydroxybutyrate &lt;91 µmol/L (lowest fourth), the multivariable adjusted hazard ratio for all-cause mortality was 1.18 (1.11-1.26). Corresponding values for higher plasma glycerol and β-hydroxybutyrate were 1.37 (1.18-1.59) and 1.18 (1.03-1.35) for cardiovascular mortality, 1.24 (1.11-1.39) and 1.16 (1.05-1.29) for cancer mortality, and 1.45 (1.28-1.66) and 1.23 (1.09-1.39) for other mortality, respectively. Results were robust to exclusion of first years of follow-up, to stratification for covariates including plasma triglycerides and body mass index, and to further adjustments.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study observed an increased risk of all-cause, cardiovascular, cancer, and other mortality with higher triglyceride metabolism. This was not explained by higher plasma triglycerides and body mass index. The hypothesis studied in the present paper should be further validated by isotope flux studies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37575001/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37575001</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad330>10.1093/eurheartj/ehad330</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37575001</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Mia Ø Johansen</dc:creator>
<dc:creator>Shoaib Afzal</dc:creator>
<dc:creator>Signe Vedel-Krogh</dc:creator>
<dc:creator>Sune F Nielsen</dc:creator>
<dc:creator>George Davey Smith</dc:creator>
<dc:creator>Børge G Nordestgaard</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>From plasma triglycerides to triglyceride metabolism: effects on mortality in the Copenhagen General Population Study</dc:title>
<dc:identifier>pmid:37575001</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad330</dc:identifier>
</item>
<item>
<title>Glycerol and β-hydroxybutyrate: friends or foes?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37574968/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 14:ehad368. doi: 10.1093/eurheartj/ehad368. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37574968/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37574968</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad368>10.1093/eurheartj/ehad368</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37574968</guid>
<pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Lale Tokgözoğlu</dc:creator>
<dc:creator>Angela Pirillo</dc:creator>
<dc:creator>Alberico Luigi Catapano</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Glycerol and β-hydroxybutyrate: friends or foes?</dc:title>
<dc:identifier>pmid:37574968</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad368</dc:identifier>
</item>
<item>
<title>A neural circuit for male sexual behavior and reward</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37572660/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>Male sexual behavior is innate and rewarding. Despite its centrality to reproduction, a molecularly specified neural circuit governing innate male sexual behavior and reward remains to be characterized. We have discovered a developmentally wired neural circuit necessary and sufficient for male mating. This circuit connects chemosensory input to BNSTpr^(Tac1) neurons, which innervate POA^(Tacr1) neurons that project to centers regulating motor output and reward. Epistasis studies demonstrate that...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 8:S0092-8674(23)00798-5. doi: 10.1016/j.cell.2023.07.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Male sexual behavior is innate and rewarding. Despite its centrality to reproduction, a molecularly specified neural circuit governing innate male sexual behavior and reward remains to be characterized. We have discovered a developmentally wired neural circuit necessary and sufficient for male mating. This circuit connects chemosensory input to BNSTpr<sup>Tac1</sup> neurons, which innervate POA<sup>Tacr1</sup> neurons that project to centers regulating motor output and reward. Epistasis studies demonstrate that BNSTpr<sup>Tac1</sup> neurons are upstream of POA<sup>Tacr1</sup> neurons, and BNSTpr<sup>Tac1</sup>-released substance P following mate recognition potentiates activation of POA<sup>Tacr1</sup> neurons through Tacr1 to initiate mating. Experimental activation of POA<sup>Tacr1</sup> neurons triggers mating, even in sexually satiated males, and it is rewarding, eliciting dopamine release and self-stimulation of these cells. Together, we have uncovered a neural circuit that governs the key aspects of innate male sexual behavior: motor displays, drive, and reward.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37572660/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37572660</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.021>10.1016/j.cell.2023.07.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37572660</guid>
<pubDate>Sat, 12 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniel W Bayless</dc:creator>
<dc:creator>Chung-Ha O Davis</dc:creator>
<dc:creator>Renzhi Yang</dc:creator>
<dc:creator>Yichao Wei</dc:creator>
<dc:creator>Vinicius Miessler de Andrade Carvalho</dc:creator>
<dc:creator>Joseph R Knoedler</dc:creator>
<dc:creator>Taehong Yang</dc:creator>
<dc:creator>Oscar Livingston</dc:creator>
<dc:creator>Akira Lomvardas</dc:creator>
<dc:creator>Gabriela J Martins</dc:creator>
<dc:creator>Ana Mafalda Vicente</dc:creator>
<dc:creator>Jun B Ding</dc:creator>
<dc:creator>Liqun Luo</dc:creator>
<dc:creator>Nirao M Shah</dc:creator>
<dc:date>2023-08-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A neural circuit for male sexual behavior and reward</dc:title>
<dc:identifier>pmid:37572660</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.021</dc:identifier>
</item>
<item>
<title>Prevention and treatment of diuretic resistance in acute heart failure: when to use which combination of diuretics?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37572039/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 14;44(31):2978-2981. doi: 10.1093/eurheartj/ehad463.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37572039/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37572039</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad463>10.1093/eurheartj/ehad463</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37572039</guid>
<pubDate>Sat, 12 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Pieter Martens</dc:creator>
<dc:creator>Jeffrey Testani</dc:creator>
<dc:creator>Kevin Damman</dc:creator>
<dc:date>2023-08-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Prevention and treatment of diuretic resistance in acute heart failure: when to use which combination of diuretics?</dc:title>
<dc:identifier>pmid:37572039</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad463</dc:identifier>
</item>
<item>
<title>Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37571968/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 12:ehad441. doi: 10.1093/eurheartj/ehad441. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37571968/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37571968</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad441>10.1093/eurheartj/ehad441</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37571968</guid>
<pubDate>Sat, 12 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alon Barsheshet</dc:creator>
<dc:creator>Ilan Goldenberg</dc:creator>
<dc:date>2023-08-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes</dc:title>
<dc:identifier>pmid:37571968</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad441</dc:identifier>
</item>
<item>
<title>Fostering heart team values: the fourth Belgrade Valve International Symposium</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37571854/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 12:ehad494. doi: 10.1093/eurheartj/ehad494. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37571854/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37571854</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad494>10.1093/eurheartj/ehad494</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37571854</guid>
<pubDate>Sat, 12 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Marko Banovic</dc:creator>
<dc:creator>Svetozar Putnik</dc:creator>
<dc:creator>Bernard Iung</dc:creator>
<dc:date>2023-08-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Fostering heart team values: the fourth Belgrade Valve International Symposium</dc:title>
<dc:identifier>pmid:37571854</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad494</dc:identifier>
</item>
<item>
<title>Creation of next generation of diverse cardiovascular physician-scientists from developing countries: insights from Research Council of Pakistan</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37571853/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 12:ehad493. doi: 10.1093/eurheartj/ehad493. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37571853/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37571853</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad493>10.1093/eurheartj/ehad493</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37571853</guid>
<pubDate>Sat, 12 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Muhammad Shahzeb Khan</dc:creator>
<dc:creator>Kaneez Fatima</dc:creator>
<dc:creator>Javed Butler</dc:creator>
<dc:date>2023-08-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Creation of next generation of diverse cardiovascular physician-scientists from developing countries: insights from Research Council of Pakistan</dc:title>
<dc:identifier>pmid:37571853</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad493</dc:identifier>
</item>
<item>
<title>CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37565345/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Intramyocardial injections of the CCND2-cardiomyocyte SMRTs promoted cardiomyocyte proliferation, reduced infarct size, and improved cardiac performance in small and large mammalian hearts with MI.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 11. doi: 10.1161/CIRCRESAHA.123.322929. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Experiments in mammalian models of cardiac injury suggest that the cardiomyocyte-specific overexpression of CCND2 (cyclin D2, in humans) improves recovery from myocardial infarction (MI). The primary objective of this investigation was to demonstrate that our specific modified mRNA translation system (SMRTs) can induce CCND2 expression in Cardiomyocytes and replicate the benefits observed in other studies of cardiomyocyte-specific CCND2 overexpression for myocardial repair.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The CCND2-cardiomyocyte-specific modified mRNA translation system (cardiomyocyte SMRTs) consists of 2 modRNA constructs: 1 code for CCND2 and contains a binding site for L7Ae, and the other codes for L7Ae and contains recognition elements for the cardiomyocyte-specific microRNAs miR-1 and miR-208. Thus, L7Ae suppresses CCND2 translation in noncardiomyocytes but is itself suppressed by endogenous miR-1 and -208 in cardiomyocytes, thereby facilitating cardiomyocyte-specific CCND2 expression. Experiments were conducted in both mouse and pig models of MI, and control assessments were performed in animals treated with an SMRTs coding for the cardiomyocyte-specific expression of luciferase or GFP, in animals treated with L7Ae modRNA alone or with the delivery vehicle, and in Sham-operated animals.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: CCND2 was abundantly expressed in cultured, postmitotic cardiomyocytes 2 days after transfection with the CCND2-cardiomyocyte SMRTs, and the increase was accompanied by the upregulation of markers for cell-cycle activation and proliferation (eg, Ki67 and Aurora B kinase). When the GFP-cardiomyocyte SMRTs were intramyocardially injected into infarcted mouse hearts, the GFP signal was observed in cardiomyocytes but no other cell type. In both MI models, cardiomyocyte proliferation (on day 7 and day 3 after treatment administration in mice and pigs, respectively) was significantly greater, left-ventricular ejection fractions (days 7 and 28 in mice, days 10 and 28 in pigs) were significantly higher, and infarcts (day 28 in both species) were significantly smaller in animals treated with the CCND2-cardiomyocyte SMRTs than in any other group that underwent MI induction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Intramyocardial injections of the CCND2-cardiomyocyte SMRTs promoted cardiomyocyte proliferation, reduced infarct size, and improved cardiac performance in small and large mammalian hearts with MI.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37565345/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37565345</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322929>10.1161/CIRCRESAHA.123.322929</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37565345</guid>
<pubDate>Fri, 11 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jiacheng Sun</dc:creator>
<dc:creator>Lu Wang</dc:creator>
<dc:creator>Rachel C Matthews</dc:creator>
<dc:creator>Gregory P Walcott</dc:creator>
<dc:creator>Yu-An Lu</dc:creator>
<dc:creator>Yuhua Wei</dc:creator>
<dc:creator>Yang Zhou</dc:creator>
<dc:creator>Lior Zangi</dc:creator>
<dc:creator>Jianyi Zhang</dc:creator>
<dc:date>2023-08-11</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs</dc:title>
<dc:identifier>pmid:37565345</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322929</dc:identifier>
</item>
<item>
<title>Valvular heart disease and cardiomyopathy: reappraisal of their interplay</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37563454/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>Cardiomyopathies and valvular heart diseases are typically considered distinct diagnostic categories with dedicated guidelines for their management. However, the interplay between these conditions is increasingly being recognized and they frequently coexist, as in the paradigmatic examples of dilated cardiomyopathy and hypertrophic cardiomyopathy, which are often complicated by the occurrence of mitral regurgitation. Moreover, cardiomyopathies and valvular heart diseases can have a shared...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Aug 10. doi: 10.1038/s41569-023-00911-0. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiomyopathies and valvular heart diseases are typically considered distinct diagnostic categories with dedicated guidelines for their management. However, the interplay between these conditions is increasingly being recognized and they frequently coexist, as in the paradigmatic examples of dilated cardiomyopathy and hypertrophic cardiomyopathy, which are often complicated by the occurrence of mitral regurgitation. Moreover, cardiomyopathies and valvular heart diseases can have a shared aetiology because several genetic or acquired diseases can affect both the cardiac valves and the myocardium. In addition, the association between cardiomyopathies and valvular heart diseases has important prognostic and therapeutic implications. Therefore, a better understanding of their shared pathophysiological mechanisms, as well as of the prevalence and predisposing factors to their association, might lead to a different approach in the risk stratification and management of these diseases. In this Review, we discuss the different scenarios in which valvular heart diseases and cardiomyopathies coexist, highlighting the need for an improved classification and clustering of these diseases with potential repercussions in the clinical management and, particularly, personalized therapeutic approaches.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37563454/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37563454</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00911-0>10.1038/s41569-023-00911-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37563454</guid>
<pubDate>Thu, 10 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Nina Ajmone Marsan</dc:creator>
<dc:creator>Francesca Graziani</dc:creator>
<dc:creator>Maria Chiara Meucci</dc:creator>
<dc:creator>Hoi W Wu</dc:creator>
<dc:creator>Rosa Lillo</dc:creator>
<dc:creator>Jeroen J Bax</dc:creator>
<dc:creator>Francesco Burzotta</dc:creator>
<dc:creator>Massimo Massetti</dc:creator>
<dc:creator>J Wouter Jukema</dc:creator>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-08-10</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Valvular heart disease and cardiomyopathy: reappraisal of their interplay</dc:title>
<dc:identifier>pmid:37563454</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00911-0</dc:identifier>
</item>
<item>
<title>Will primordial prevention change cardiology?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37563238/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230815000922&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 11:ehad459. doi: 10.1093/eurheartj/ehad459. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37563238/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230815000922&v=2.17.9.post6+86293ac">37563238</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad459>10.1093/eurheartj/ehad459</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37563238</guid>
<pubDate>Thu, 10 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Eugene Braunwald</dc:creator>
<dc:date>2023-08-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Will primordial prevention change cardiology?</dc:title>
<dc:identifier>pmid:37563238</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad459</dc:identifier>
</item>





























</channel>
</rss>